Notes - Segment Information, Etc.

Carna Biosciences, Inc. - Filing #7272198

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
636,235,000 JPY
636,235,000 JPY
636,235,000 JPY
JPY
JPY
1,625,889,000 JPY
918,239,000 JPY
1,625,889,000 JPY
707,650,000 JPY
JPY
Transactions with other segments
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Other items
Depreciation
23,330,000 JPY
31,245,000 JPY
31,245,000 JPY
JPY
7,914,000 JPY
35,612,000 JPY
23,298,000 JPY
35,612,000 JPY
12,313,000 JPY
JPY
Increase in property, plant and equipment and intangible assets
8,662,000 JPY
17,828,000 JPY
17,828,000 JPY
JPY
9,166,000 JPY
44,550,000 JPY
39,369,000 JPY
44,550,000 JPY
5,180,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.